Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial
Non-Small Cell Lung Cancer
Overall survival vs immunohistochemistry. The Kaplan Meier graph... | Download Scientific Diagram
BioCentury - The latest twist in the overall survival debate
Oncotarget: Identification intermediate-risk | EurekAlert!
CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up
Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy - Clinical Genitourinary Cancer
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma - Figure f3 | Aging
Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink
Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC
Kaplan–Meier curves showing recurrence-free survival and overall... | Download Scientific Diagram
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system - Figure f1 | Aging
